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Abstract
Although all brain cells bear in principle a comparable potential in terms of energetics, in reality they exhibit different
metabolic profiles. The specific biochemical characteristics explaining such disparities and their relative importance are
largely unknown. Using a modeling approach, we show that modifying the kinetic parameters of pyruvate dehydrogenase
and mitochondrial NADH shuttling within a realistic interval can yield a striking switch in lactate flux direction. In this
context, cells having essentially an oxidative profile exhibit pronounced extracellular lactate uptake and consumption.
However, they can be turned into cells with prominent aerobic glycolysis by selectively reducing the aforementioned
parameters. In the case of primarily oxidative cells, we also examined the role of glycolysis and lactate transport in providing
pyruvate to mitochondria in order to sustain oxidative phosphorylation. The results show that changes in lactate transport
capacity and extracellular lactate concentration within the range described experimentally can sustain enhanced oxidative
metabolism upon activation. Such a demonstration provides key elements to understand why certain brain cell types
constitutively adopt a particular metabolic profile and how specific features can be altered under different physiological and
pathological conditions in order to face evolving energy demands.
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Introduction
A central question in biology concerns the biochemical
characteristics that determine the metabolic profile (glycolytic vs.
oxidative) of a particular cell type. Indeed, since the experimental
description of aerobic glycolysis (i.e. the conversion of glucose into
lactate despite the presence of sufficient oxygen levels to carry out
oxidative metabolism) by Warburg [1,2], this issue has become
crucial to understand the process of tumorigenicity [3,4,5,6].
Notwithstanding, numerous studies (including those of Warburg)
have also documented the occurrence of aerobic glycolysis in
several non-cancer cell types [7,8,9,10]. Among normal tissues, the
central nervous system was identified as partly relying on such a
metabolic process for its energy production [11,12]. At the cellular
level, it was clearly demonstrated that astrocytes exhibit a
prominent aerobic glycolytic activity [13]. In contrast, neurons
seem devoid of this capacity [14] and rather present a strongly
oxidative phenotype [15,16,17].
Such considerations acquire additional interest in the context of
cell-cell interactions and metabolic cooperation. Indeed, in several
tissues including muscles [18], testis [19], retina [20] as well as
brain [21], a process known as intercellular lactate shuttle was
reported that represents the supply of lactate produced by a
glycolytic cell for the benefit of a neighboring oxidative cell [22].
Apart from the features that determine metabolic phenotypes,
another crucial question is whether lactate provided by an
adjacent cell can fulfill the energy requirements of the oxidative
cell. For this purpose, we developed a modeling approach based
on known biochemical characteristics of glucose and lactate
metabolism. Our model allowed us to highlight key elements that
are sufficient to explain the fundamental differences between an
essentially oxidative cell and another cell exhibiting prominent
aerobic glycolysis. Moreover, we could illustrate that under most
physiological conditions, characteristics of lactate metabolism are
adequate to sustain the evolving energy needs of the oxidative cell.
Overall, the results of our modeling investigation account well for
the described individual metabolic characteristics of astrocytes and
neurons in the central nervous system, as well as for a prominent
role of lactate as an energy substrate supplied by astrocytes to
neurons, in accordance with the astrocyte-neuron lactate shuttle
(ANLS) model.
Models
Description of the model
In order to better understand the importance of distinct energy
substrate sources for brain cell energetics, we considered a simple
model taking into account glucose and lactate supply as well as
their metabolism. This model describes the dynamics of lactate
and glucose in brain cells. Fig. 1 shows a typical brain cell. Glucose
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(Glc) is metabolized into pyruvate (P) during glycolysis. This
reaction requires NAD+, which is converted into NADH. For
glycolysis to proceed, the excess NADH needs to be ‘‘recycled’’
back into NAD+. One way to do this is to convert pyruvate into
lactate (Li), a reversible reaction catalyzed by lactate dehydroge-
nase (LDH). The produced lactate can then be transported outside
the cell via the monocarboxylate transporters (MCT). The
consumption of glucose for lactate production mainly is considered
a glycolytic phenotype (red arrow in Fig. 1). Another alternative
for the cell is to use the mitochondrial shuttles, mainly the malate-
aspartate shuttle, to convert NADH into NAD+ in order to
proceed with glycolysis. This can happen provided that the cell has
enough mitochondrial activity (see Text S1 for more details). In
this scenario, the pyruvate produced by glycolysis can be further
metabolized by pyruvate dehydrogenase (PDH) into acetyl-CoA
and produce energy via oxidative phosphorylation in the
mitochondria. Since NADH is recycled into NAD+ by the
mitochondrial shuttles, lactate can be imported into the cell and
the LDH can perform the reverse reaction, converting it into
pyruvate to feed oxidative phosphorylation as well. Such a
phenotype is called oxidative (blue arrows in Fig. 1). As we will
show, this model is very general and can be applied to both
neurons and astrocytes, by modifying some biochemical condi-
tions, namely the rate of NADH recycling to NAD+ (JShuttle) and
the rate of the PDH reaction (JPDH).
In this model, lactate is taken up (or released) by brain cells via
MCTs and further metabolized by LDH into pyruvate (or
produced via this reaction). The intracellular lactate dynamics is
therefore described by the following equation:
dLi
dt
~JMCT{JLDH
where JMCT is the net transport of lactate inside the cell (i.e. if
JMCTv0, lactate is being transported outside the cell) and JLDH is
the net rate of the reaction catalyzed by LDH; no a priori
assumption is made about the sign of JMCT and JLDH .
In parallel to the LDH reaction, glucose uptake and glycolysis
contribute to the balance of pyruvate, which is further metabolized
by PDH into acetyl-CoA:
dP
dt
~JLDHzJglyco{JPDH
where Jglyco is the rate of pyruvate production by glycolysis and
JPDH is the rate of pyruvate consumption by the reaction catalyzed
by PDH. Then, acetyl-CoA is used to fuel the Krebs cycle and
eventually oxidative phosphorylation in the mitochondria.
Another important feature of our model is the role of NADH.
Indeed, both the forward LDH reaction and glycolysis produce
NADH (from NAD+), while it is ‘‘recycled’’ back into NAD+ by
the mitochondrial shuttles for the transfer of reducing equivalents:
dNADH
dt
~JLDH{JShuttlezJglyco
where JShuttle~kShuttle:NADH is the flux of mitochondrial NADH
shuttling, that we assume proportional to NADH for simplicity
(kShuttle is a constant). The NADH mitochondrial shuttle therefore
plays an essential role in determining the direction of the LDH
reaction. (See Text S1 for a detailed description of the model).
Role of lactate transport in fueling oxidative
phosphorylation
We note that the baseline steady state values (subscript 0),
obtained by equating to zero the right-hand side of all the
differential equations, obey to
Figure 1. Model describing the simplified energetics of brain
cells. Glucose undergoes glycolysis and all resulting pyruvate is either
further metabolized by PDH or converted to lactate by LDH before
being transported out of the cell. On the other hand, lactate can be
transported into the cell and then metabolized into pyruvate by LDH.
Because these processes require NAD+/NADH, we also modeled the
‘‘recycling’’ shuttle of NADH to NAD+ by mitochondria. The red arrow
shows the metabolism of a typical predominantly glycolytic cell,
characterized by lactate export; the blue arrow shows a typical
oxidative phenotype, where both glucose and lactate import contribute
to oxidative phosphorylation. Abbreviations: Le, extracellular lactate; Li,
intracellular lactate; P, pyruvate; NADH, reduced nicotinamide-adenine
dinucleotide; Glc, glucose; JMCT, transmembrane flux of lactate viaMCTs;
Jshuttle, flux of NADH to NAD
+ ‘‘recycling’’ by the mitochondria; Jglyco,
glycolytic flux; JLDH, metabolic flux via LDH; JPDH, metabolic flux via PDH.
doi:10.1371/journal.pcbi.1002686.g001
Author Summary
In an environment with appropriate oxygen levels
(normoxia), most eukaryotic cells produce energy by
oxidizing glucose into carbon dioxide and water. In this
process, glucose is transformed into pyruvate, which then
fuels oxidative phosphorylation in the mitochondria.
Interestingly, Otto Warburg reported back in the 1920’s
that some eukaryotic cells prominently process glucose-
derived pyruvate into lactate, hence ‘‘avoiding’’ the
mitochondrial oxidation despite adequate oxygen concen-
trations. This phenomenon was termed aerobic glycolysis
and was first observed in cancer cells. Since then, it has
also been described in several normal tissues including the
central nervous system. The biochemical basis of aerobic
glycolysis has remained elusive until now. Taking advan-
tage of a modeling approach, we unraveled the main
metabolic characteristics that determine whether a cell will
be strictly oxidative or rather will exhibit aerobic glycolysis.
When applied in the context of the central nervous system,
our findings not only provide a theoretical demonstration
of why neurons and astrocytes differ in terms of metabolic
profile, but also suggest that such complementarity forms
the basis for metabolic cooperation between the two cell
types.
Modeling of Brain Cell Metabolic Phenotypes
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JPDH ,0~Jglyco,0zJMCT ,0
JShuttle,0~JPDH,0:
Let us define r~
def
JMCT=Jglyco. Here we consider this ratio at basal
state, namely r~JMCT ,0=Jglyco,0. If we assume glycolysis to be
constant, we have upon activation:
(1za)JPDH,0~Jglyco,0z(1zc)JMCT ,0
where a is the increase in acetyl-CoA production and c the
increase in transport flux, yielding:
a~
c r
1zr
: ð1Þ
Thus, given the ratio r at basal state, we can easily determine what
will be the increase in oxidative phosphorylation upon transport
activation (in the case where glycolysis is fixed).
Choice of parameters
Some of the parameters in our equations, or a combination of
them, have been measured or are known to lie within some range
[17,23,24,25,26,27]. The unknown parameters were set as to
satisfy the following physiological constraints: the ratio r~
JMCT=Jglyco [ ½0:75; 2:2$ [15,16,28,29], the intracellular lac-
tate concentrations Li,0 [ ½0:35; 1:65$mM [30,31], the ratio
Li=P [ ½5; 35$ (chosen around the measured value L=P&19 in
10-day old mouse brain [32] and considering that this ratio lies
within [7;25] in human blood under various conditions [33]) and
the redox state NADH=NADz [ ½0:001; 0:01$ [34]. The param-
eters used to compute the basal state of a typical oxidative cell are
listed in Table S1. The parameters used in all the other simulations
are the same as for the oxidative cell (Table S1), except when
mentioned (see the text and figure legends where the modified
parameters are compared to the ‘‘reference’’ oxidative cell
parameters).
Results
All the figures presented in this work (except Fig. 1) were
obtained by numerically solving in MATLABH Eqs. (S1) in Text
S1. For Table 1, we used Eq. (1) (see also Models).
Key parameters defining metabolic phenotypes
(oxidative vs. glycolytic)
The model presented above was used to determine the changes
in lactate flux across the plasma membrane as well as in the
glycolytic and pyruvate dehydrogenase-catalyzed fluxes, when
switching conditions from a basal to a stimulated state. For the
basal state, the contribution of lactate-derived and glycolysis-
derived pyruvate was set to 43% and 57%, respectively (or
JMCT=Jglyco~r~0:75), in accordance with the data of Nehlig and
collaborators [29]. For the stimulated state, we allowed a 30%
increase of the PDH maximal reaction rate vmax ,PDH and of the
mitochondrial NADH shuttling kinetic constant kShuttle, with a
rather strong increase of 48.5% in the maximal glycolytic rate
vmax ,glyco as well (see Text S1 for details). In addition, three
scenarios were considered for lactate transport stimulation: 1) An
increase in vmax ,MCT , namely lactate maximal transport rate via
MCTs, of 80% based on the data of Pierre et al. obtained in
cultured neurons [35], due to MCT2 translocation to the cell
membrane 2) An in vivo increase in the extracellular lactate
concentration Le of 80% as reported by Hu and Wilson [36] 3) A
concomitant increase in vmax ,MCT and Le of the same magnitude.
Simulations allowed to determine the resulting fluxes for lactate
transport, JMCT , glycolysis, Jglyco, and oxidative metabolism,
JPDH . As can be observed in Fig. 2A, an enhancement of 30% in
oxidative metabolism is obtained when increasing vmax,glyco, kshuttle
and vmax,PDH alone (ctrl-bar). Further activating lactate transport
capacity, vmax ,MCT , in a stimulated cell yields a slight increase in
oxidative metabolism to +33%. Note that the increase in lactate
flux remains relatively modest (+13%) in this condition. If instead
an increase in the extracellular lactate concentration Le is taken
into account, oxidative metabolism is further enhanced (+42%),
with a significant increase in lactate flux (+34%). A combination of
enhanced lactate transport capacity and extracellular lactate
concentration leads to a 47% increase in oxidative metabolism
Table 1. Importance of lactate transport regulation.
r \ c 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
0.1 0.0091 0.018 0.027 0.036 0.046 0.055 0.064 0.073
0.4 0.029 0.057 0.086 0.11 0.14 0.17 0.20 0.23
0.7 0.041 0.082 0.12 0.16 0.21 0.25 0.29 0.33
1.0 0.050 0.10 0.15 0.20 0.25 0.30 0.35 0.40
1.3 0.057 0.11 0.17 0.23 0.28 0.34 0.40 0.45
1.6 0.062 0.12 0.18 0.25 0.31 0.37 0.43 0.49
1.9 0.066 0.13 0.20 0.26 0.33 0.39 0.46 0.52
2.2 0.069 0.14 0.21 0.28 0.34 0.41 0.48 0.55
2.5 0.071 0.14 0.21 0.29 0.36 0.43 0.50 0.57
2.8 0.074 0.15 0.22 0.29 0.37 0.44 0.52 0.59
3.1 0.076 0.15 0.23 0.30 0.38 0.45 0.53 0.60
3.4 0.077 0.15 0.23 0.31 0.39 0.46 0.54 0.62
Increases of oxidative metabolism, JPDH, obtained with distinct ratios of lactate/glycolysis-derived pyruvate, r, and different increases in lactate transport flux, c (cf. Eq.
(1)). Roman: below 10%; italic: between 10 and 29%; boldface: above 29%.
doi:10.1371/journal.pcbi.1002686.t001
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with a concomitant 45% increase in lactate flux. It is noteworthy
that in this last case, the contribution of each metabolic pathway
approaches the basal state contributions (r=0.73). Based on these
metabolic responses, such a behavior appears characteristic of
oxidative cells.
It is well known that a certain fraction of brain cells do not
respond to a stimulation by importing lactate but rather by
producing and releasing lactate. In order to reproduce this specific
behavior, some of the parameters had to be modified. We found
that reducing both the initial PDH reaction rate and the activity of
the mitochondrial NADH shuttles leads to a strikingly different
type of response. Fig. 2B presents the result of simulations
performed when the basal values for these parameters were set to
0:3:vmax ,PDH and 0:2:kShuttle as compared to the simulations in
Fig. 2A. Moreover, in the stimulated cell, the increase in PDH
activity was limited to 15% and no increase in the kinetic constant
of mitochondrial NADH shuttle was allowed (instead of +30% for
both parameters in Fig. 2A, see Text S1 for details). In such case, a
stimulation causing an activation of glycolysis and lactate transport
produced a more limited increase in oxidative metabolism (+12%),
but importantly yielded a prominent release of lactate (+91%), as
indicated by the negative sign of the flux. Increasing the
extracellular lactate concentration did not prevent lactate export
(+67%), and oxidative metabolism was increased (+32%). In this
Figure 2. Jshuttle and vmax,PDH determine the occurrence of oxidative vs. glycolytic phenotype. (A) Oxidative phenotype: In the basal state
(black), both lactate transport and glycolysis contribute to JPDH (43% and 57% respectively [29]). We show the resulting steady state transport,
glycolytic and JPDH fluxes upon stimulation (very dark gray ‘‘ctrl-bar’’: +30% vmax,PDH, +30% kshuttle, +48.5% vmax,glyco; dark gray: +80% vmax,MCT,, +30%
vmax,PDH, +30% kshuttle, +48.5% vmax,glyco; light gray: +80% Le, +30% vmax,PDH, +30% kshuttle, +48.5% Jmax,glyco; white: +80% vmax,MCT, +80% Le, +30%
vmax,PDH, +30% kshuttle, +48.5% vmax,glyco). (B) Glycolytic phenotype: In the basal state (black), parameters have been chosen such that lactate is taken
out of the cell (vglycolyticmax ,PDH~0:3
:voxidativemax ,PDH , k
glycolytic
shuttle ~0:2
:koxidativeshuttle ). We show the resulting steady state transport, glycolytic and JPDH fluxes upon
stimulation (very dark gray ‘‘ctrl-bar’’: +30% vmax,PDH, +30% kshuttle, +48.5% vmax,glyco; dark gray: +80% vmax,MCT, +15% vmax,PDH, +0% kshuttle, +48.5%
vmax,glyco; light gray: +80% Le, +15% vmax,PDH, +0% kshuttle, +48.5% vmax,glyco; white: +80% Le, +80% vmax,MCT, +15% vmax,PDH, +0% kshuttle, +48.5%
vmax,glyco). See Description of the model for equations and Choice of parameters for parameters. (C–D) Basal lactate transport (C) and oxidative
metabolism (D) when varying vmax,PDH and kshuttle. We considered 20 different values evenly spaced in the range ½0:1:voxidativemax ,PDH ; 2:voxidativemax ,PDH $ and
½0:1:koxidative
shuttle
; 2:koxidative
shuttle
$, resulting in 400 simulations. For each simulation, we recorded the steady state value of JMCT and JPDH. We show the resulting
iso-curves (note that vmax,PDH and kshuttle were normalized to their basal oxidative value, so that (1,1) (marked by ‘o’) corresponds to the parameters
used in Fig. 2A and (0.2,0.3) (marked by ‘g’) corresponds to the parameters used in Fig. 2B). In non-shaded regions, the ratio Li=P [ 5; 35½ $ [32],
Li [ ½0:35; 1:65$ and NADH=NADz [ ½0:001; 0:01$ [34].
doi:10.1371/journal.pcbi.1002686.g002
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case, the observed metabolic behavior rather corresponds to a
typical predominantly glycolytic cell. Fig. 2C–D shows the basal
lactate transport (C) and oxidative metabolism (D) obtained when
varying both vmax,PDH and kshuttle, normalized to their basal
oxidative reference values. On one hand, increases in vmax,PDH
and/or kshuttle can significantly increase pyruvate consumption by
mitochondria, JPDH. This result can also be interpreted in the
context of neural stimulation, showing that a stimulation of the
NADH shuttles, especially the malate-aspartate shuttle, can
usefully contribute to the increase in oxidative phosphorylation.
On the other hand, decreasing vmax,PDH and/or kshuttle leads to a
glycolytic phenotype, with lactate secretion by the cell. Interest-
ingly, while strongly reducing either vmax,PDH or kshuttle is sufficient
to switch from a basal oxidative to a glycolytic phenotype, these
parameters need to be tuned together in order for the cell to
preserve physiological lactate and pyruvate levels (non-shaded
areas).
Importance of lactate metabolism in sustaining oxidative
metabolism
It could be observed in the previous simulations that lactate
metabolism can significantly contribute to an enhancement in
oxidative metabolism in cells with a predominantly oxidative
phenotype (Fig. 2A). In these simulations, the presence of a strong
glycolytic component was considered in parallel with lactate
metabolism. However, evidence from the literature suggests that
this is not the case in certain brain cell types, neurons in particular
[14]. Thus, we investigated the capacity of lactate metabolism to
sustain enhanced oxidative metabolism under fixed glycolytic
conditions. Four scenarios were studied combining two lactate/
glycolysis-supplied pyruvate ratios, JMCT/Jglyco= r, at basal state,
and two distinct levels of activation of the oxidative rate, vmax ,PDH :
r=0.75, +30% vmax ,PDH (Fig. 3A); r=0.75, +70% vmax ,PDH
(Fig. 3B); r=2.2, +30% vmax ,PDH (Fig. 3C); and r=2.2, +70%
vmax ,PDH (Fig. 3D). In each case, a series of incremental oxidative
fluxes were delineated, allowing to determine the combination of
increased lactate transport capacity and extracellular lactate
concentration that can sustain each oxidative flux (note that
concentrations remained within physiological limits in all cases, cf.
Choice of parameters). As can be seen, a rather wide range of
increased oxidative rates can be accounted for by altering lactate
transport capacity and extracellular lactate concentration. Impor-
tantly too, we see that increasing the PDH maximal capacity
vmax,PDH by 30% (respectively 70%) is not sufficient to yield an
Figure 3. Importance of lactate transport for oxidative phosphorylation in oxidative cells. (A) As a starting point, it was assumed that
lactate transport and glycolysis contribute 43% and 57%, respectively, to oxidative phosphorylation (r= 0.75 [29]). Lactate transport was then
stimulated by increasing vmax,MCT and Le in the range 0–80%. The iso-curves show JPDH normalized to its basal value (as a measure of oxidative
phosphorylation). Note that in parallel, vmax,PDH and kshuttle were multiplied by a factor f=1.3, while the glycolytic flux remained fixed to its basal level.
In all regions, the ratio Li=P [ 5; 35½ $ [32] and NADH=NADz [ ½0:001; 0:01$ [34]. (B) As in (A), but f= 1.7. (C) As in (A), but r= 2.2 [28]. (D) As in (A), but
r= 2.2 [28] and f=1.7. See Description of the model for equations and Choice of parameters for parameters.
doi:10.1371/journal.pcbi.1002686.g003
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increase in oxidative metabolism JPDH of 30% (respectively 70%).
Hence, in order to be efficient under fixed glycolysis, the cell
should not rely exclusively on the regulation of the PDH activity to
increase its production of energy. In parallel, it should also
enhance lactate transport, meaning that the latter could become
limiting upon activation.
In order to better delineate under which range of basal
conditions a change in lactate metabolism alone can satisfy
physiological increases in oxidative rate, we varied the lactate/
glycolysis-supplied pyruvate ratio, JMCT,0/Jglyco,0,= r, between
extreme cases (0.1 to 3.4 with increments of 0.3) together with
increases c in lactate flux of up to 80% (see Table 1; note that in
this case, vmax,glyco, kshuttle and vmax,PDH were not enhanced, because
the calculation is based here on Eq. (1)). As can be observed,
increases in oxidative rate JPDH of up to 10% (white), between
10% and 29% (light gray), or even above 29% (dark gray) can be
easily accounted by physiological increases in lactate flux for a
wide range of basal conditions which encompasses most published
values [15,28,29] (see also Evaluation of model validity with in vitro and
in vivo experimental data).
Evaluation of model validity with in vitro and in vivo
experimental data
It is important to assess the validity of the model by testing
whether it can account for published data. First, a ratio at basal
state r= JMCT/Jglyco=0.69/0.31= 2.2 as determined in vivo by
Hyder et al. [28] was modeled with plausible flux rates for lactate
transport, JMCT, glycolysis, Jglyco, and oxidative metabolism, JPDH
(Fig. 4A in black). Of interest, it gave rise to physiological
intracellular lactate and pyruvate concentrations of 0.36 mM and
0.018 mM respectively, resulting in a lactate/pyruvate ratio of
19.5. Note that we used an extracellular lactate concentration of
1.1 mM and that the glycolysis flux was reduced by 49% to
account for the data (compared to the oxidative cell of Fig. 2A).
When considering in vitro data of Bouzier-Sore et al. [15] in
cultured neurons, we used a ratio r=0.76/0.24 = 3.2 with an
extracellular lactate concentration of 1.1 mM as in the experi-
mental condition (Fig. 4A, dark gray). Interestingly, increasing the
extracellular lactate concentration to 5.5 mM, as used in Bouzier-
Sore et al. [16], led to a higher but still quite plausible intracellular
pyruvate concentration of 0.039 mM (Fig. 4A, light gray) and to a
ratio r=4.1, which is significantly lower than the corresponding
experimental ratio (8). Reducing the glycolytic flux by 60% yielded
a pyruvate concentration of 0.036 mM (Fig. 4A, white). In such
case, we obtained a ratio r=0.92/0.08= 11.5, which matches the
experimental results.
Finally, we decided to assess under conditions close to those
observed in vivo whether lactate metabolism can account for a
significant enhancement in oxidative rates following brain
activation. Changes in lactate, glycolytic and oxidative fluxes
following a stimulation were determined with the model using the
experimental in vivo data of Hyder et al. [28], i.e. a ratio r=0.69/
0.31= 2.2 and a resting extracellular lactate concentration of
1.1 mM (Fig. 4B). Three stimulated conditions were considered:
increased lactate transport rate of 80% (Fig. 4B, dark gray),
increased extracellular lactate concentration of 80% (Fig. 4B, light
gray), and a combination of both (Fig. 4B, white). An increase in
oxidative capacity of 70% was applied in parallel for all three
stimulated conditions, as proposed by Hyder et al. [28]. As can be
seen, the increase in lactate transport capacity or the extracellular
lactate concentration led to an increase in oxidative flux of 67%
and 72% respectively. But even more strikingly, a combination of
the two parameters gave rise to an even more significant 86%
increase in oxidative rate.
Figure 4. Model validity tested for different experimental conditions. (A) Black: r= JMCT/Jglyco= 0.69/0.31= 2.2 at basal state, as evaluated in
vivo by Hyder et al. [28], with physiological values for intracellular lactate (Li) and pyruvate (P) concentrations (0.36 and 0.018 mM, respectively).
Le = 1.1 mM. Dark gray: r= JMCT/Jglyco=0.76/0.24= 3.2, as observed in vitro by Bouzier-Sore et al. [15], with the experimentally used Le=1.1 mM. Light
gray: Le was increased to 5.5 mM, as described in the experiment by Bouzier-Sore et al. [16], resulting in a higher, but still plausible, value of 0.039 mM
for intracellular pyruvate; r= 4.1. White: Same conditions as in light gray, but the glycolytic rate was lowered by 60%, resulting in a lower intracellular
pyruvate concentration of 0.036 mM and a JMCT/Jglyco ratio equal to 0.92/0.08= 11.5, which matches experimental results by Bouzier-Sore et al. [16].
(B) Effect of lactate transport enhancement in the case of a basal JMCT/Jglyco ratio (r) equal to 0.69/0.31= 2.2, as evaluated in vivo by Hyder et al. [28], cf.
black bar in (A). Basal state: Le=1.1 mM (black). Stimulations: +30% vmax,PDH, +30% kshuttle, +48.5% vmax,glyco (very dark gray, ctrl-bar); +0% Le, +80%
vmax,MCT, +70% vmax,PDH, +70% kshuttle (dark gray); +80% Le, +0% vmax,MCT, +70% vmax,PDH, +70% kshuttle (light gray); +80% Le, +80% vmax,MCT, +70%
vmax,PDH, +70% kshuttle (white).
doi:10.1371/journal.pcbi.1002686.g004
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Discussion
A critical question in neuroenergetics concerns the metabolic
differences among the various brain cell types, and in particular
between neurons and astrocytes. Several studies performed over the
last 60 years using various approaches have documented distinctive
features between these two cell types. Thus, using enzymatic analyses
on individually isolated cells, Hyde´n and colleagues have suggested
that neurons favor oxidative metabolism while glial cells rather
exhibit a prominent glycolytic activity [37,38]. With the advent of
magnetic resonance spectroscopy applied in vivo or on purified
preparations of both astrocytes and neurons in culture, several
groups have confirmed the prominence of glycolysis in astrocytes
and a more active tricarboxylic acid cycle in neurons [15,39,40,41].
An important issue however is to determine which enzymatic
elements could confer such a particular metabolic profile to these
brain cell types. In this context, transcriptomic studies have all
pointed out that astrocytes contain higher levels of several glycolytic
enzymes than neurons [42,43,44]. In addition, studies on the
distribution of isoforms of key proteins involved in lactate
metabolism have been found to be consistent with astrocytes being
glycolytic cells that export lactate, while neurons would be better
equipped to oxidize it [25,45,46,47]. Despite these pieces of
evidence, it is still difficult to assess to what extent each specific
element is critical to determine the particular metabolic profile
observed in each brain cell type and how physiological metabolite
concentrations are maintained. In this regard, our model provides a
simple answer to this question. It revealed that altering the activity of
only two components, the enzyme pyruvate dehydrogenase (PDH)
and the mitochodrial NADH shuttling capacity, was sufficient to
obtain two distinct metabolic phenotypes while preserving physio-
logical concentrations. These phenotypes are characterized by their
differential lactate metabolism. In the first case, cells use lactate as an
oxidative energy substrate and are considered predominantly
oxidative. The second phenotype exhibits lactate production and is
associated with a rather glycolytic profile.
Interestingly, experimental evidence have been provided for a
key role of these two enzymatic processes in the metabolic profile
of brain cells. It was shown that neurons in culture oxidize readily
substrates like lactate, which is not the case for cultured astrocytes
that rather produce lactate [17]. But when astrocytes were treated
with dichloroacetate, a substance that prevents PDH phosphor-
ylation and enhances its activity, it promoted lactate oxidation and
reduced its production from glucose. Indeed, it was shown that
PDH activity is strongly inhibited constitutively in astrocytes via its
phosphorylation while the neuronal PDH operates close to its
maximal level [48] (ratio of 0.25 for vmax,PDH between astrocytes
and neurons, similar to our value of 0.3 used in Fig. 2B). Such an
observation indicates that the level of PDH activity is key to
determine the oxidative capacity of the cell. In addition to the level
of PDH activity, it was observed that astrocytes and neurons differ
in terms of mitochondrial NADH shuttling activity, especially the
malate/aspartate shuttle which is the most important NADH
shuttle in the brain (ratio of 0.26 for kShuttle between astrocytes and
neurons [49], similar to our value of 0.2 used in Fig. 2B). Thus, it
was documented that astrocytes, in contrast to neurons, express
very low levels of an essential component of the mitochondrial
malate/aspartate NADH shuttle, the mitochondrial aspartate/
glutamate transporter also known as aralar [49]. It was also
demonstrated that glial cells have a low activity of the malate/
aspartate shuttle [50,51]. Moreover, when the mitochondrial
aspartate/glutamate transporter was invalidated via a transgenic
approach, cultured neurons from KO mice exhibited enhanced
lactate production [52]. These data support the concept that a less
efficient mitochondrial NADH shuttling mechanism, as observed
in astrocytes, is associated with increased lactate production, as
predicted by our model. Further analyses on the importance of
PDH activity vs. mitochondrial NADH shuttling capacity also
revealed that the level of active PDH determines the maximal
oxidative capacity of the cell while varying mitochondrial shuttling
rate allows rapid adjustments in oxidative rate (see Fig. S1 and
Section Effect of mitochondrial NADH shuttle vs. PDH parameters in Text
S2). In this sense, it has been shown that cytoplasmic Ca2+ levels
control the activity of aralar [53,54] and yield increased pyruvate
levels, suggesting that adjustments of the NADH shuttle, via the
control of cytoplasmic Ca2+ levels, act like a ‘‘gas pedal’’ [55].
Interestingly, it can be noticed that the oxidative and glycolytic
profiles described in our model would fit well with the described
behavior of a majority of neurons and astrocytes, respectively.
However, it is not excluded that some neurons and/or astrocytes
might exhibit a constitutively different metabolic profile or that
they might alter their behavior as a function of activation, if their
characteristics resemble those highlighted herein (see a modeling
example of such a cell in Fig. S2 and in Section Lactate export at rest
– lactate consumption upon activation in Text S2).
Recent evidence suggest that lactate represents an important
oxidative energy substrate for the brain [56,57] and more
specifically for neurons in vivo [58]. These data add to numerous
others obtained over decades in various in vitro preparations
indicating that lactate represents a preferential oxidative energy
substrate over glucose in neurons [15,16,17]. A key question
remaining was to what extent lactate oxidation can sustain the
observed enhancement in oxidative metabolism occurring in brain
cells following cerebral activation. In theory, lactate competes with
glucose-derived pyruvate as an oxidative substrate, although we
could demonstrate a substantial contribution of lactate to
enhanced oxidative metabolism despite a strong rise in glycolysis
in the stimulated condition. It was recently demonstrated however
that cultured neurons cannot exhibit an enhancement in their
glycolytic rate, as they lack an important component of the
glycolytic regulatory cascade [14]. This situation is highly
favorable to the use of lactate over glucose as a preferred oxidative
substrate in these cells. Taking this point into account, our
simulations demonstrate that under a wide range of initial
glucose/lactate utilization ratios, most physiological increases in
oxidative metabolism can be accounted for by realistic changes in
lactate flux obtained by modifying either transport capacity,
extracellular lactate concentration, or both. It is important to
mention that following appropriate stimulation, both an increase
in extracellular lactate concentration [36] and an increase in
lactate transport capacity due to MCT2 membrane translocation
in neurons [35] have been documented, providing physiological
mechanisms for the modeling predictions. It was also important to
consider other factors that can influence lactate flux under
physiological conditions, in particular the pH changes known to
occur following activation, and the LDH parameters. First of all, it
was determined that upon stimulation, the observed pH changes
would be favorable to both lactate transport and oxidation within
an oxidative cell, as it would be the case in a neuron (see Fig. S3
and Section Effect of intracellular and extracellular pH values in Text S2).
In contrast, it is interesting to notice that pH changes occurring
with glutamate uptake in astrocytes prevent this glycolytic cell type
to oxidize pyruvate and rather promote lactate release [59].
Concerning LDH, it could be shown that the responses obtained
for an oxidative cell remain the same with different concentrations
of total LDH (over a very wide range), suggesting that LDH
activity does not represent a limiting factor for lactate oxidation at
steady state (see Fig. S4 and Section Effect of LDH parameters in Text
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S2); however this does not preclude a physiological role of the
distribution of LDH isoforms between neurons and astrocytes
during fast transients. Similarly, using various equations for lactate
transport via MCTs does not modify the results obtained, as long
as the importance of the proton gradient is taken into account, a
point that was neglected in previous modeling efforts ([60]; see Fig.
S5 and Section Effect of MCT parameters and alternative equation for
MCT transport in Text S2).
Finally, it was important to determine whether modeled cells
could account for the experimental results obtained both in vitro
and in vivo [15,16,28]. Indeed, it was the case but interestingly,
modeling revealed that the glycolytic rate must be lower in
cultured neurons compared to in vivo (cf. Fig. 4A). This is not
surprising since the population of oxidative cells in vivo most likely
displays a greater heterogeneity in terms of glycolytic rate than the
selected population of neurons in vitro. Indeed, a low and rather
uniform glycolytic rate was measured in cultured neurons as
opposed to other cell types using an appropriate FRET
nanosensor [61]. In contrast, the glycolytic rate measured for
neurons in acute hippocampal slices by the same method was
much more variable. Notwithstanding, the glycolytic rate in
neurons (either in cultured neurons or in slices) was found to be on
average much lower than in astrocytes [61], a feature which
further emphasizes the importance of exogenous (astrocyte-
derived) lactate vs. glucose-derived pyruvate to sustain oxidative
metabolism in neurons. Another interesting prediction of our
model concerns the importance of lactate transport capacity for
lactate release by astrocytes and consumption by neurons. In fact,
the capacity of astrocytes to provide lactate to surrounding cells
upon stimulation seems directly dependent on both lactate
transport and glycolysis capacities (cf. Fig. 2B, dark gray bar,
where glycolysis was increased by 48% and transport capacity by
80%, yielding a significant increase in lactate export of +91%). In
parallel, neurons would rely on both increased lactate transport
capacity and extracellular lactate concentration to support their
energetic needs upon stimulation (cf. Fig. 3 and Table 1). In this
regard, the recent observation that the expression of the
monocarboxylate transporter MCT4 can be raised in astrocytes
by nitric oxide, leading to enhanced lactate release, provides a
mechanism to fulfil this predicted feature [62]. It remains to be
determined whether a faster mechanism (e.g. membrane translo-
cation) exists and would allow for rapid adaptation of lactate
supply by astrocytes in register with neuronal activity, as is the case
for MCT2 to facilitate lactate uptake in neurons [35].
Although the main findings of our modeling effort have been
applied in the context of neuroenergetics, it is important to
emphasize that implications extend far beyond. Indeed, cell-cell
lactate shuttles have been reported in several other tissues, e.g.
skeletal muscle [18,22]. It is purported that the concept developed in
the present work can be generalized to several physiological
situations and may provide the main governing principles of cellular
metabolic specialization as well as cell-cell metabolic cooperation in
various biological organisms [63,64,65]. Furthermore, it could be
applied to pathologies and explain certain characteristics of their
development. For example, as observed by Warburg [2], many
tumor cells exhibit aerobic glycolysis which gives them a key
advantage to survive in a hypoxic environment, although others
continue to rely on oxidativemetabolism. In fact, our model provides
a simple biochemical description of the Warburg effect. More
recently, it was observed that oxidative tumor cells lying close to
blood vessels consume lactate from more distant hypoxic tumor cells
in order to spare glucose for these cells, thus favoring growth of the
tumor [66]. In such case, our model offers a theoretical framework to
describe the optimal conditions leading to disease progression. Based
on such tools, perhaps it can be hoped that we could not only better
understand factors that determine the evolution of various diseases,
but it may also open up new therapeutic perspectives.
Supporting Information
Figure S1 PDH-metabolic flux as a function of the mitochon-
drial NADH shuttling rate kshuttle and the maximal velocity of the
PDH reaction, vmax,PDH, which is proportional to the total amount
of active PDH. The simulations in the gray areas did not match
the following physiological constraints (cf. Choice of parameters in
the main text): intracellular lactate concentrations Li [
½0:35; 1:65$mM [30,31], ratio Li=P [ ½5; 35$ and redox state
NADH=NADz [ ½0:001; 0:01$ [34]. The black area represents
the simulation with the parameters used for a typical oxidative cell
(cf. Fig. 2A and Table S1).
(TIF)
Figure S2 NALS at rest, ANLS upon activation. (A) In the basal
state (black), parameters are chosen such that lactate is taken out of
the cell (vmax ,PDH~0:6
:voxidativemax ,PDH , kshuttle~0:6
:koxidativeshuttle , vmax ,glyco
~1:3:voxidativemax ,glyco). We show the resulting transport, glycolytic and
JPDH fluxes upon stimulation (dark gray: +80% vmax,MCT, +100%
vmax,PDH, +70% kshuttle, +0% vmax,glyco; light gray: +80% Le,
+100% vmax,PDH, +70% kshuttle, +0% vmax,glyco; white: +80%
vmax,MCT, +80% Le, +100% vmax,PDH, +70% kshuttle, +0%
vmax,glyco). (B) Same as (A), but glycolysis is also enhanced upon
stimulation (+48.5% vmax,glyco). Cf. Table S1 for the parameters of
a typical oxidative cell.
(TIF)
Figure S3 Effect of pH on transport, glycolysis and PDH-
metabolic flux. All the rates are normalized relative to their
maximum. The intracellular proton concentration Hzi was varied
within the range of [1023.6; 1024.8] mM; for the other parameters,
refer to Table S1. The simulations in the gray areas did not
match the following physiological constraints (cf. Choice of parameters
in the main text): intracellular lactate concentrations Li [
½0:35; 1:65$mM [30,31], ratio Li=P [ ½5; 35$ and redox state
NADH=NADz [ ½0:001; 0:01$ [34]. * represents the simulation
with the parameters used for a typical oxidative cell (cf. Fig. 2A
and Table S1).
(TIF)
Figure S4 Changing the LDH pool. (A) Effect of the total LDH
pool on transport, glycolysis and PDH-metabolic flux. The
simulations in the gray area did not match the following
physiological constraints (cf. Choice of parameters in the main text):
intracellular lactate concentrations Li[½0:35; 1:65$mM [30,31],
ratio Li=P[½5; 35$ and redox state NADH=NADz[½0:001; 0:01$
[34]. * represents the simulation with the parameters used for a
typical oxidative cell ([LDH]total = 3.2 mM, cf. Fig. 2A and Table
S1). (B) [LDH]total = 0.064 mM (compare with Fig. 2A of the main
text where [LDH]total = 3.2 mM). In the basal state (black), both
glycolysis and lactate transport contribute to JPDH (57% and 43%
respectively). We show the resulting transport, glycolytic and JPDH
fluxes upon stimulation (dark gray: +80% vmax,MCT, +30% vmax,PDH,
+30% kshuttle, +48.5% vmax,glyco; light gray: +80% Le, +30%
vmax,PDH, +30% kshuttle, +48.5% vmax,glyco; white: +80% vmax,MCT,
+80% Le, +30% vmax,PDH, +30% kshuttle, +48.5% vmax,glyco).
(TIF)
Figure S5 Effect of MCT parameters (transport equation in
[60]). (A) Oxidative phenotype: In the basal state (black), both
lactate transport and glycolysis contribute to JPDH (43% and 57%
respectively [29]). We show the resulting steady state transport,
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glycolytic and JPDH fluxes upon stimulation (dark gray: +80%
vmax,MCT, +30% vmax,PDH, +30% kshuttle, +48.5% vmax,glyco; light
gray: +80% Le, +30% vmax,PDH, +30% kshuttle, +48.5% vmax,glyco;
white: +80% vmax,MCT, +80% Le, +30% vmax,PDH, +30% kshuttle,
+48.5% vmax,glyco). (B) Glycolytic phenotype: In the basal state
(black), parameters are chosen such that lactate is taken out of the
cell (vglycolyticmax ,PDH~0:3
:voxidativemax ,PDH , k
glycolytic
shuttle ~0:2
:koxidativeshuttle ). We show
the resulting steady state transport, glycolytic and JPDH fluxes
upon stimulation (dark gray: +80% vmax,MCT, +15% vmax,PDH,
+0% kshuttle, +48.5% vmax,glyco; light gray: +80% Le, +15%
vmax,PDH, +0% kshuttle, +48.5% vmax,glyco; white: +80% Le, +80%
vmax,MCT, +15% vmax,PDH, +0% kshuttle, +48.5% vmax,glyco). See
Supp. Table S1 for the parameters of a typical oxidative cell. For
lactate transport, we used vmax ,MCT~125=(39|10
{15)s{1 and
the parameters in [60].
(TIF)
Table S1 Parameters used in our simulations to compute the
basal state of a typical oxidative cell (cf. Fig. 2A). For the
references, refer to the bibliography in Text S1.
(DOC)
Text S1 Model description.
(DOC)
Text S2 Model robustness.
(DOC)
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